Zimislecel for hypoglycemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Mar 2021: Trial registered, NCT04786262
  2. 29 Mar 2021: Trial started, NCT04786262

The trials

NCT04786262: A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

State
Under way
Phase
Phase 3
People
57 planned
Started
29 Mar 2021
Primary completion
31 Dec 2027
Arms
VX-880
Results
None posted
  1. 8 Mar 2021: Trial registered
  2. 29 Mar 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.